Synergistic effects of TNF-a and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study
1996

Effects of TNF-a and Melphalan on Tumors in Rats

Sample size: 71 publication Evidence: moderate

Author Information

Author(s): PTGA Nooijen, ER Manusama, AMM Eggermont, L Schalkwijk, J Stavast, RL Marquet, RMW de Waal, DJ Ruiter

Primary Institution: University Hospital Nijmegen and University Hospital Rotterdam

Hypothesis

The study aims to analyze the morphological substrate for the synergistic response of TNF-a in combination with melphalan in an isolated limb perfusion model.

Conclusion

The combination of TNF-a and melphalan enhances anti-tumor effects through increased vascular changes and permeability.

Supporting Evidence

  • ILP with TNF-a and melphalan showed more extensive necrosis compared to controls.
  • Complete regression occurred in 75% of rats treated with both drugs.
  • Histological analysis revealed significant vascular changes after treatment.

Takeaway

Researchers tested a treatment for tumors in rats using two drugs, TNF-a and melphalan, and found that using them together worked better than using either one alone.

Methodology

The study used an isolated limb perfusion model in rats with a non-immunogenic sarcoma, analyzing histopathological changes after treatment with TNF-a, melphalan, and their combination.

Limitations

The study was conducted in a rat model, which may not fully replicate human responses.

Participant Demographics

Male BN strain rats, weighing 250-300 g.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication